Mon. 5 Feb 2024, 2:33pm ET
Benzinga
Biotech, News, General
Sangamo Therapeutics Gets European Medicines Agency PRIME Designation For Isaralgagene Civaparvovec For Treatment Of Fabry Disease
Company Profile